Bengaluru: About 20 deaths linked to serious liver dysfunction have been reported in Japan in patients treated with Amgen's ...
The Manila Times on MSN
Japan pharma firm warns against rare diseases drug after deaths
TOKYO — A Japanese pharmaceutical firm has warned doctors against prescribing a drug for rare autoimmune diseases to new patients following the deaths of 20 people who took it. Kissei Pharmaceutical, ...
Twenty people in Japan died after taking Tavneos, though it's unclear whether the drug killed those people, a media report ...
Amgen (AMGN) stock is in focus as partner Kissei (KSPHF) reports 20 deaths linked to the U.S. company's rare disease drug.
Tokyo: The Japanese pharmaceutical company Kissei Pharmaceutical has advised doctors not to prescribe its rare disease ...
Johnson & Johnson is counting on its newly launched psoriasis pill to become its next cash cow. Investors want to know if it ...
Japan's Kissei Pharmaceutical Co. has started urging doctors to refrain from using Tavneos, a drug used to treat rare kidney diseases ...
Kissei Pharmaceutical's notice to healthcare professionals came after 20 deaths possibly linked to the drug were reported in Japan.
About 20 deaths linked to serious liver dysfunction have been reported in Japan in patients treated with Amgen's rare disease ...
Kissei Pharmaceutical, which sells the rare immune-disease drug in Japan, warned doctors to stop prescribing it to new ...
May 15 () - At least 20 people in Japan who took Amgen's rare disease drug have died, while 22 others developed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results